share_log

Maxim Group Maintains Buy on Trxade Health, Lowers Price Target to $1.75

Maxim Group Maintains Buy on Trxade Health, Lowers Price Target to $1.75

Maxim集团维持对Trxade Health的买入,将目标价下调至1.75美元
Benzinga ·  2023/03/28 10:04

Maxim Group analyst Allen Klee maintains Trxade Health (NASDAQ:MEDS) with a Buy and lowers the price target from $2.5 to $1.75.

Maxim Group分析师Allen Klee维持Trxade Health(纳斯达克:MEDS)的买入,并将目标价从2.5美元下调至1.75美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发